Investor List:

Top Pharmaceuticals Series A Investors in London (33)

INVESTORSINTRO STRENGTHSWEET SPOT (RANGE)INVESTMENT LOCATIONSTOP INVESTMENT CATEGORIES
n/a
$25.0M
($10.0M - $350.0M)
Investors in London
+21
n/a
$2.8M
($500K - $5.0M)
Investors in London, Investors in New York (NY)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series B), Investors in London (Other Lists), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in DeepTech (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Series B), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in DeepTech (Series B), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in Pharmaceuticals (Pre-seed), Investors in DeepTech (Series B), Investors in DeepTech (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Therapeutics (Series A), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in DeepTech (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Series B), Investors in BioTech (Pre-seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed)
+58
n/a
$2.0M
($1M - $3.0M)
Investors in United Kingdom, Investors in London
Investors in Retail (Seed), Investors in Analytics (Series A), Investors in Pharmaceuticals (Seed), Investors in Security (Seed), Investors in Analytics (Seed), Investors in Retail (Series A), Investors in Security (Series A), Investors in AI (Seed), Investors in Diverse Investors (Other Lists), Investors in AI (Series A), Investors in Pharmaceuticals (Series A), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Analytics (Seed), Investors in Marketplaces (Series A), Investors in AI (Seed), Investors in Investors who invested in diverse founders (Other Lists), Investors in Consumer Internet (Seed), Investors in Marketplaces (Seed), Investors in Consumer Internet (Seed), Investors in Retail (Seed), Investors in SaaS (Seed), Investors in Security (Seed), Investors in Pharmaceuticals (Seed), Investors in AI (Series A), Investors in Analytics (Series A), Investors in Consumer Internet (Series A), Investors in Marketplaces (Series A), Investors in Retail (Series A), Investors in Security (Series A), Investors in SaaS (Series A), Investors in Pharmaceuticals (Series A), Investors in London (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Enterprise Applications (Series A), Investors in Enterprise Applications (Seed), Investors in Enterprise Applications (Series A), Investors in Enterprise Applications (Seed), Investors in Pharmaceuticals (Pre-seed), Investors in Retail (Pre-seed), Investors in Analytics (Pre-seed), Investors in Security (Pre-seed), Investors in AI (Pre-seed), Investors in Enterprise Applications (Pre-seed), Investors in Digital Health (Pre-seed), Investors in AI (Pre-seed), Investors in Analytics (Pre-seed), Investors in Consumer Internet (Pre-seed), Investors in Marketplaces (Pre-seed), Investors in SaaS (Pre-seed), Investors in Security (Pre-seed), Investors in Marketplaces (Pre-seed), Investors in Retail (Pre-seed), Investors in SaaS (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Consumer Internet (Pre-seed), Investors in Enterprise Applications (Pre-seed), Investors in Digital Health (Pre-seed), Investors in SaaS (Series A), Investors in Consumer Internet (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Marketplaces (Seed), Investors in SaaS (Seed)
+62
Photo of Bali Muralidhar, Managing Partner at Abingworth
n/a
$22.5M
($15.0M - $30.0M)
Investors in London
Photo of Andrew Kozlov, Managing Partner at 4BIO Capital
n/a
$1.5M
($100K - $5.0M)
Investors in London
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in London (Other Lists), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A)
+9
Photo of Shahzad Malik, General Partner at Advent Life Sciences
n/a
$1M
($25K - $5.0M)
Investors in London
Photo of Robert Thong, General Partner at Selvedge Venture
n/a
$1.5M
($100K - $5.0M)
Investors in London
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Enterprise (Seed), Investors in Enterprise (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Enterprise (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in London (Other Lists), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Enterprise Applications (Series A), Investors in Enterprise Applications (Seed), Investors in Enterprise Applications (Series A), Investors in Enterprise Applications (Seed), Investors in Pharmaceuticals (Pre-seed), Investors in Health IT (Pre-seed), Investors in Enterprise Applications (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Enterprise (Pre-seed), Investors in Enterprise (Pre-seed), Investors in Health IT (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Enterprise Applications (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Enterprise (Seed)
+39
n/a
$1.5M
($100K - $5.0M)
Investors in London
+21
Know someone who's actively diligencing and investing? Add them to this list.